Mulakan
ReutersReuters

Champions Oncology Inc expected to post a loss of 20 cents a share - Earnings Preview

RefinitivBacaan kurang dari 1 minit
CSBR

  • Champions Oncology Inc CSBR is expected to show a fall in quarterly revenue when it reports results on July 16 (estimated) for the period ending April 30 2025

  • The Hackensack New Jersey-based company is expected to report a 14.2% decrease in revenue to $12.013 million from $14 million a year ago, according to the estimate from one analyst, based on LSEG data.

  • ​LSEG's mean analyst estimate for Champions Oncology Inc is for a loss of 20 cents per share.

  • The one available analyst rating on the shares is "buy".

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Champions Oncology Inc is $12.00, about 32.5% above its last closing price of $8.10

AmerikaReutersSaham AS
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini

Lebih berita dari Reuters